Zur Kurzanzeige

2014-04-11Zeitschriftenartikel DOI: 10.1186/1472-6823-14-33
Prevalence and determinants of osteoporosis in patients with type 1 and type 2 diabetes mellitus
dc.contributor.authorLeidig-Bruckner, Gudrun
dc.contributor.authorGrobholz, Sonja
dc.contributor.authorBruckner, Thomas
dc.contributor.authorScheidt-Nave, Christa
dc.contributor.authorNawroth, Peter
dc.contributor.authorSchneider, Jochen G.
dc.date.accessioned2018-05-07T17:38:14Z
dc.date.available2018-05-07T17:38:14Z
dc.date.created2014-04-30
dc.date.issued2014-04-11none
dc.identifier.otherhttp://edoc.rki.de/oa/articles/re6SPzXmMQzBM/PDF/299tHTQ2nXcBU.pdf
dc.identifier.urihttp://edoc.rki.de/176904/1866
dc.description.abstractBackground: Increased risk of osteoporosis and its clinical significance in patients with diabetes is controversial. We analyze osteoporosis prevalence and determinants of bone mineral density (BMD) in patients with type 1 and 2 diabetes. Methods: Three hundred and ninety-eight consecutive diabetic patients from a single outpatient clinic received a standardized questionnaire on osteoporosis risk factors, and were evaluated for diabetes-related complications, HbA1c levels, and lumbar spine (LS) and femoral neck (FN) BMD. Of these, 139 (71 men, 68 women) type 1 and 243 (115 men, 128 women) type 2 diabetes patients were included in the study. BMD (T-scores and values adjusted for age, BMI and duration of disease) was compared between patient groups and between patients with type 2 diabetes and population-based controls (255 men, 249 women). Results: For both genders, adjusted BMD was not different between the type 1 and type 2 diabetes groups but was higher in the type 2 group compared with controls (p eng
dc.language.isoeng
dc.publisherRobert Koch-Institut, Epidemiologie und Gesundheitsberichterstattung
dc.subjectOsteoporosiseng
dc.subjectBone mineral densityeng
dc.subjectDiabetes mellituseng
dc.subjectFractureseng
dc.subjectVascular complicationseng
dc.subject.ddc610 Medizin
dc.titlePrevalence and determinants of osteoporosis in patients with type 1 and type 2 diabetes mellitus
dc.typeperiodicalPart
dc.identifier.urnurn:nbn:de:0257-10036256
dc.identifier.doi10.1186/1472-6823-14-33
dc.identifier.doihttp://dx.doi.org/10.25646/1791
local.edoc.container-titleBMC Endocrine Disorders
local.edoc.fp-subtypeArtikel
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-urlhttp://www.biomedcentral.com/1472-6823/14/33/abstract
local.edoc.container-publisher-nameBioMedCentral
local.edoc.container-volume14
local.edoc.container-issue33
local.edoc.container-year2014

Zur Kurzanzeige